Sign up to receive Rapport
Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research.
Sue Rees & Helen Ansell - July 2017
Complete the form below to watch the webcast.
With women accounting for half of the global population, women’s healthcare is an important market for the pharmaceutical industry. When thinking about women’s health, we tend to think about diseases which are linked specifically to female biology.
Complete the form below to watch the webcast.
With women accounting for half of the global population, women’s healthcare is an important market for the pharmaceutical industry. When thinking about women’s health, we tend to think about diseases which are linked specifically to female biology.
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat.
However, it is important to not over-simplify this definition; women’s healthcare also includes diseases which are more prevalent in women and health purchasing behaviour which is more common among females (e.g. aesthetic treatment) all of which present huge opportunities for the pharma industry.
Furthermore despite persistent gender wage gaps, women globally earn and own more than ever before and are expected to control nearly 75 percent of discretionary spending worldwide by 2028. In emerging markets, the women's health space is also deeply influenced by gender roles and societal attitudes to sex and reproduction. It is extremely dynamic from a global perspective; as such, the opportunity for women’s health varies widely from one country to another. An understanding of this and the associated challenges is fundamental when defining and establishing the opportunity for pharmaceutical companies in this area.
What are the key takeaways?
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat.